spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  GliaSite 

 HSMN NewsFeed - 14 Jan 2016
IsoRay Appoints Thomas LaVoy as CEO to Take Office on February 15
Devices Oncology Personnel
 HSMN NewsFeed - 5 Aug 2014
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery
Devices Neurosurgery Oncology
 HSMN NewsFeed - 20 Jun 2014
IsoRay Announces New Russian and Peruvian International Distributor Agreements for the Sale of IsoRay's Full Line of Products
Devices Oncology Distribution
 HSMN NewsFeed - 12 May 2014
IsoRay's Liquid Cesium-131 (Cesitrex(R)) Recieves Final Regulatory Approval for Use in GliaSite(R) Brain Cancer Treatment System
Devices Oncology Regulatory
 HSMN NewsFeed - 29 Jan 2014
IsoRay Receives Five Year CE Mark Extension for All Cesium-131 Seed Products
Devices Oncology Regulatory
 HSMN NewsFeed - 7 Jan 2014
FDA Clears IsoRay's Liquid Cesium (Cesitrex)(TM) for Use With GliaSite(R) in Treating Glioblastomas and Metastatic Brain Cancers
Devices Oncology FDA
 HSMN NewsFeed - 19 Dec 2013
University of California San Diego and John Muir Medical Center Initiate Treating Patients for Colon and Lung Cancer Utilizing IsoRay's Cesium-131 Seeded Mesh
Devices Oncology
 HSMN NewsFeed - 25 Jun 2013
IsoRay Announces a New International Distributor in Australia and New Zealand
Devices Oncology Distribution
 HSMN NewsFeed - 29 Oct 2012
IsoRay's Brain and Lung Cancer Products Showcased at the American Society for Radiation Oncology (ASTRO) Convention
Devices Oncology
 HSMN NewsFeed - 5 Jun 2012
IsoRay Announces World's First Cesium-131 Mesh Treatment for Meningioma Brain Tumors
Devices Neurosurgery Oncology
 HSMN NewsFeed - 22 May 2012
IsoRay’s GliaSite Approved for Sale in 31 European Countries
Devices Oncology Regulatory
 HSMN NewsFeed - 7 May 2012
IsoRay to Introduce GliaSite and Cesium-131 Mesh to International Audience at World Congress of Brachytherapy
Devices Oncology
 HSMN NewsFeed - 22 Nov 2011
IsoRay Receives Final Regulatory Approval for GliaSite(R) Brain Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 3 Nov 2011
IsoRay Announces Major International Distribution Agreement for GliaSite(R)
Devices Oncology Distribution
 HSMN NewsFeed - 12 Sep 2011
FDA Clears IsoRay's GliaSite(R) Treatment for Brain Cancer
Devices Oncology FDA
 HSMN NewsFeed - 7 Jun 2011
IsoRay Acquires Exclusive Worldwide License for Liquid Iodine Iotrex(R) for GliaSite(R) Brain Cancer Treatment
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 23 Jun 2010
IsoRay and Hologic Sign Exclusive Worldwide License for Crucial Brain Cancer Treatment Device
Devices Oncology Licensing
 HSMN NewsFeed - 16 Mar 2007
Cytyc Corporation Completes Acquisition of Adiana, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 14 Mar 2007
Cytyc Corporation Announces Expiration of Antitrust Waiting Period for Adeza Biomedical Corporation Tender Offer
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 27 Feb 2007
Cytyc to Acquire Adiana, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 12 Feb 2007
Cytyc to Acquire Adeza Biomedical Corporation
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 30 Jan 2007
Cytyc Announces New UK NICE Clinical Guideline Recommends Endometrial Ablation Instead of Hysterectomy For Most Women with Heavy Menstrual Bleeding
Devices
 HSMN NewsFeed - 15 Nov 2006
Eight Studies Evaluating Cytyc's Novasure(R) System Presented at AAGL Meeting
Devices
 HSMN NewsFeed - 13 Nov 2006
Twelve Studies Evaluating Cytyc's MammoSite(R) Radiation Therapy System Presented at ASTRO Annual Meeting
Devices Oncology
 HSMN NewsFeed - 25 Oct 2006
Cytyc to Introduce Cellient(TM) Automated Cell Block System at American Society of Cytopathology Annual Meeting
Devices Diagnostics
 HSMN NewsFeed - 25 Oct 2006
Cytyc Acquires Minimally Invasive Surgical Device for Treating Endometriosis
Devices Surgery Acquisitions
 HSMN NewsFeed - 5 Oct 2006
Cytyc Statement on Termination of Merger Implementation Agreement between Vision Systems and Ventana
Devices Diagnostics Oncology Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 23

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 23 additional stories matching:
GliaSite
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.